Rock Springs Capital Management LP Gilead Sciences, Inc. Transaction History

Rock Springs Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $26 Million - $28.8 Million	-365,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $3.35 Million - $3.91 Million	51,600 Added 16.46%	365,000 $25.9 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $22.6 Million - $26.8 Million	313,400	313,400 $25.4 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.